EVALUATION OF TRANEXAMIC ACID AND CALCIUM CHLORIDE IN MAJOR TRAUMAS IN A PREHOSPITAL SETTING: A NARRATIVE REVIEW.
Journal
Shock (Augusta, Ga.)
ISSN: 1540-0514
Titre abrégé: Shock
Pays: United States
ID NLM: 9421564
Informations de publication
Date de publication:
01 09 2023
01 09 2023
Historique:
medline:
13
9
2023
pubmed:
21
7
2023
entrez:
21
7
2023
Statut:
ppublish
Résumé
Excessive blood loss in the prehospital setting poses a significant challenge and is one of the leading causes of death in the United States. In response, emergency medical services (EMS) have increasingly adopted the use of tranexamic acid (TXA) and calcium chloride (CaCl 2 ) as therapeutic interventions for hemorrhagic traumas. Tranexamic acid functions by inhibiting plasmin formation and restoring hemostatic balance, while calcium plays a pivotal role in the coagulation cascade, facilitating the conversion of factor X to factor Xa and prothrombin to thrombin. Despite the growing utilization of TXA and CaCl 2 in both prehospital and hospital environments, a lack of literature exists regarding the comparative effectiveness of these agents in reducing hemorrhage and improving patient outcomes. Notably, Morgan County Indiana EMS recently integrated the administration of TXA with CaCl 2 into their treatment protocols, offering a valuable opportunity to gather insight and formulate updated guidelines based on patient-centered outcomes. This narrative review aims to comprehensively evaluate the existing evidence concerning the administration of TXA and CaCl 2 in the prehospital management of hemorrhages, while also incorporating and analyzing data derived from the co-administration of these medications within the practices of Morgan County EMS. This represents the inaugural description of the concurrent use of both TXA and CaCl 2 to manage hemorrhages in the scientific literature.
Identifiants
pubmed: 37477447
doi: 10.1097/SHK.0000000000002177
pii: 00024382-990000000-00237
pmc: PMC10510828
doi:
Substances chimiques
Tranexamic Acid
6T84R30KC1
Calcium Chloride
M4I0D6VV5M
Antifibrinolytic Agents
0
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
325-332Informations de copyright
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Shock Society.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest.
Références
J Trauma. 2008 Oct;65(4):951-60
pubmed: 18849817
Eur J Trauma Emerg Surg. 2016 Jun;42(3):273-82
pubmed: 26847110
Lancet. 2010 Jul 3;376(9734):23-32
pubmed: 20554319
J Trauma Acute Care Surg. 2021 Feb 1;90(2):396-402
pubmed: 33196630
Wilderness Environ Med. 2017 Jun;28(2S):S50-S60
pubmed: 28601210
Minerva Anestesiol. 2015 Jan;81(1):65-75
pubmed: 24608516
Can Fam Physician. 2012 Feb;58(2):158-62
pubmed: 22439169
Emerg Med J. 2016 Aug;33(8):569-72
pubmed: 26848163
Mil Med. 2021 Jan 25;186(Suppl 1):300-304
pubmed: 33499442
J Pharm Pract. 2014 Oct;27(5):474-7
pubmed: 24326409
Ann Neurol. 2016 Jan;79(1):18-26
pubmed: 26580862
Transfusion. 2022 Aug;62 Suppl 1:S158-S166
pubmed: 35748676
Anesth Analg. 2017 Sep;125(3):895-901
pubmed: 28704250
J Trauma Acute Care Surg. 2019 Jan;86(1):20-27
pubmed: 30239375
Crit Care. 2021 Aug 4;25(1):277
pubmed: 34348782
J Trauma Acute Care Surg. 2014 Aug;77(2):213-8
pubmed: 25058244
J Trauma Acute Care Surg. 2020 Mar;88(3):434-439
pubmed: 31876689
Shock. 2020 Mar;53(3):277-283
pubmed: 32044848
J Biomed Mater Res A. 2014 Nov;102(11):4182-94
pubmed: 24307256
Crit Care. 2021 Nov 1;25(1):380
pubmed: 34724964
J Trauma Acute Care Surg. 2020 May;88(5):588-596
pubmed: 32317575
Arch Surg. 2012 Feb;147(2):113-9
pubmed: 22006852
West J Emerg Med. 2017 Jun;18(4):673-683
pubmed: 28611888
Chest. 2016 Mar;149(3):846-55
pubmed: 26836894
Crit Care. 2016 May 12;20(1):143
pubmed: 27176727
Crit Care. 2019 Mar 27;23(1):98
pubmed: 30917843
AANA J. 2020 Oct;88(5):383-389
pubmed: 32990208
J Surg Res. 2016 May 1;202(1):182-7
pubmed: 27083965
Emerg Med J. 2018 Mar;35(3):176-179
pubmed: 29175878
J Emerg Med. 2013 Apr;44(4):829-38
pubmed: 23375220